GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cogstate Ltd (OTCPK:COGZF) » Definitions » Loans Receivable

Cogstate (Cogstate) Loans Receivable : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Cogstate Loans Receivable?

Cogstate's Loans Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.


Cogstate Loans Receivable Historical Data

The historical data trend for Cogstate's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cogstate Loans Receivable Chart

Cogstate Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cogstate Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cogstate Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Cogstate Loans Receivable Related Terms

Thank you for viewing the detailed overview of Cogstate's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Cogstate (Cogstate) Business Description

Traded in Other Exchanges
Address
161 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cogstate Ltd is a cognitive science company. The principal activity of the company is the sale of technology and services for the measurement of cognition, where services include scientific consultancy, project management, data management, statistical analysis, and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.